-
1
-
-
0344915699
-
International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
-
Cvitkovic E,; International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys. 1996; 35: 463-469.
-
(1996)
Int J Radiat Oncol Biol Phys.
, vol.35
, pp. 463-469
-
-
Cvitkovic, E.1
-
2
-
-
0031947875
-
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
-
Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998; 16: 1310-1317.
-
(1998)
J Clin Oncol.
, vol.16
, pp. 1310-1317
-
-
Al-Sarraf, M.1
Leblanc, M.2
Giri, P.G.3
-
3
-
-
0037441720
-
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival
-
Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003; 21: 631-637.
-
(2003)
J Clin Oncol.
, vol.21
, pp. 631-637
-
-
Lin, J.C.1
Jan, J.S.2
Hsu, C.Y.3
-
4
-
-
27244452301
-
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
-
Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005; 23: 6730-6738.
-
(2005)
J Clin Oncol.
, vol.23
, pp. 6730-6738
-
-
Wee, J.1
Tan, E.H.2
Tai, B.C.3
-
5
-
-
33644668130
-
Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: Preliminary results
-
Zhang L, Zhao C, Peng PJ, et al. Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results. J Clin Oncol. 2005; 23: 8461-8468.
-
(2005)
J Clin Oncol.
, vol.23
, pp. 8461-8468
-
-
Zhang, L.1
Zhao, C.2
Peng, P.J.3
-
6
-
-
47149084927
-
Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China
-
Chen Y, Liu MZ, Liang SB, et al. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys. 2008; 71: 1356-1364.
-
(2008)
Int J Radiat Oncol Biol Phys.
, vol.71
, pp. 1356-1364
-
-
Chen, Y.1
Liu, M.Z.2
Liang, S.B.3
-
7
-
-
58249089750
-
Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant decetaxel and cisplatin in advanced nasopharyngeal carcinoma
-
Hui EP, Ma BB, Leung SF, et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant decetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol. 2009; 27: 242-249.
-
(2009)
J Clin Oncol.
, vol.27
, pp. 242-249
-
-
Hui, E.P.1
Ma, B.B.2
Leung, S.F.3
-
8
-
-
77955445967
-
Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced
-
Lee AW, Tung SY, Chua DT, et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced. J Natl Cancer Inst. 2010; 102: 1188-1198.
-
(2010)
J Natl Cancer Inst.
, vol.102
, pp. 1188-1198
-
-
Lee, A.W.1
Tung, S.Y.2
Chua, D.T.3
-
9
-
-
78651367213
-
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma
-
Lee AW, Tung SY, Chan ATC, et al. A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Radiother Oncol. 2011; 98: 15-22.
-
(2011)
Radiother Oncol.
, vol.98
, pp. 15-22
-
-
Lee, A.W.1
Tung, S.Y.2
Chan, A.T.C.3
-
10
-
-
14544304586
-
Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: A pooled data analysis of 2 phase III trials
-
Chua DT, Ma J, Sham JS, et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of 2 phase III trials. J Clin Oncol. 2005; 23: 1118-1124.
-
(2005)
J Clin Oncol.
, vol.23
, pp. 1118-1124
-
-
Chua, D.T.1
Ma, J.2
Sham, J.S.3
-
11
-
-
15944417086
-
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
-
Chan ATC, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2005; 97: 536-539.
-
(2005)
J Natl Cancer Inst.
, vol.97
, pp. 536-539
-
-
Chan, A.T.C.1
Leung, S.F.2
Ngan, R.K.3
-
12
-
-
0025089749
-
Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification
-
Chang YS, Tyan YS, Liu ST, et al. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol. 1990; 28: 2398-2402.
-
(1990)
J Clin Microbiol.
, vol.28
, pp. 2398-2402
-
-
Chang, Y.S.1
Tyan, Y.S.2
Liu, S.T.3
-
13
-
-
0027491589
-
Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization
-
Chen CL, Wen WN, Chen JY, et al. Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization. Intervirology. 1993; 36: 91-98.
-
(1993)
Intervirology.
, vol.36
, pp. 91-98
-
-
Chen, C.L.1
Wen, W.N.2
Chen, J.Y.3
-
14
-
-
0034086769
-
Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: An aid for differentiating the primary site
-
Lee WY, Hsiao JR, Jin YT, et al. Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck. 2000; 22: 336-240.
-
(2000)
Head Neck.
, vol.22
, pp. 336-240
-
-
Lee, W.Y.1
Hsiao, J.R.2
Jin, Y.T.3
-
15
-
-
0030022339
-
Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes
-
Tsai ST, Jin YT, Su IJ,. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes. Cancer. 1996; 77: 231-236.
-
(1996)
Cancer.
, vol.77
, pp. 231-236
-
-
Tsai, S.T.1
Jin, Y.T.2
Su, I.J.3
-
16
-
-
0028802725
-
Role of Epstein-Barr virus in fine-needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma
-
Macdonald MR, Freeman JL, Hui MF, et al. Role of Epstein-Barr virus in fine-needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma. Head Neck. 1995; 17: 487-493.
-
(1995)
Head Neck.
, vol.17
, pp. 487-493
-
-
MacDonald, M.R.1
Freeman, J.L.2
Hui, M.F.3
-
17
-
-
0029980163
-
Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma
-
Chao TY, Chow KC, Chang JY, et al. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma. Cancer. 1996; 78: 24-29.
-
(1996)
Cancer.
, vol.78
, pp. 24-29
-
-
Chao, T.Y.1
Chow, K.C.2
Chang, J.Y.3
-
18
-
-
0033559576
-
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma
-
Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999; 59: 1188-1191.
-
(1999)
Cancer Res.
, vol.59
, pp. 1188-1191
-
-
Lo, Y.M.1
Chan, L.Y.2
Lo, K.W.3
-
19
-
-
0033229898
-
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma
-
Lo YM, Chan LY, Chan ATC, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 1999; 59: 5452-5455.
-
(1999)
Cancer Res.
, vol.59
, pp. 5452-5455
-
-
Lo, Y.M.1
Chan, L.Y.2
Chan, A.T.C.3
-
20
-
-
0034671947
-
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA
-
Lo YM, Chan ATC, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res. 2000; 60: 6878-6881.
-
(2000)
Cancer Res.
, vol.60
, pp. 6878-6881
-
-
Lo, Y.M.1
Chan, A.T.C.2
Chan, L.Y.3
-
21
-
-
0037032506
-
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma
-
Chan ATC, Lo YM, Zee B, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst. 2002; 94: 1614-1619.
-
(2002)
J Natl Cancer Inst.
, vol.94
, pp. 1614-1619
-
-
Chan, A.T.C.1
Lo, Y.M.2
Zee, B.3
-
22
-
-
0037669569
-
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of post-therapy distant failure in patients with early stage nasopharyngeal carcinoma of undifferentiated type
-
Leung SF, Chan ATC, Zee B, et al. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of post-therapy distant failure in patients with early stage nasopharyngeal carcinoma of undifferentiated type. Cancer. 2003; 98: 288-291.
-
(2003)
Cancer.
, vol.98
, pp. 288-291
-
-
Leung, S.F.1
Chan, A.T.C.2
Zee, B.3
-
23
-
-
33847742531
-
Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma
-
Leung SF, Zee B, Ma BB, et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol. 2006; 24: 5414-5418.
-
(2006)
J Clin Oncol.
, vol.24
, pp. 5414-5418
-
-
Leung, S.F.1
Zee, B.2
Ma, B.B.3
-
24
-
-
2942607684
-
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
-
Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2004; 350: 2461-2470.
-
(2004)
N Engl J Med.
, vol.350
, pp. 2461-2470
-
-
Lin, J.C.1
Wang, W.Y.2
Chen, K.Y.3
-
25
-
-
34547448675
-
Long-term prognostic effects of plasma Epstein-Barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy
-
Lin JC, Wang WY, Liang WM, et al. Long-term prognostic effects of plasma Epstein-Barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2007; 68: 1342-1348.
-
(2007)
Int J Radiat Oncol Biol Phys.
, vol.68
, pp. 1342-1348
-
-
Lin, J.C.1
Wang, W.Y.2
Liang, W.M.3
-
26
-
-
79251644435
-
Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy
-
Hou X, Zhao Chong, Guo Y, et al. Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy. Clin Oncol. 2011; 23: 128-133.
-
(2011)
Clin Oncol.
, vol.23
, pp. 128-133
-
-
Hou, X.1
Chong, Z.2
Guo, Y.3
-
27
-
-
23844440912
-
A comparison study of different PCR assays in measuring circulating plasma Epstein-Barr virus DNA levels in patients with nasopharyngeal carcinoma
-
Le QT, Jones CD, Yau TK, et al. A comparison study of different PCR assays in measuring circulating plasma Epstein-Barr virus DNA levels in patients with nasopharyngeal carcinoma. Clin Cancer Res. 2005; 11: 5700-5707.
-
(2005)
Clin Cancer Res.
, vol.11
, pp. 5700-5707
-
-
Le, Q.T.1
Jones, C.D.2
Yau, T.K.3
-
28
-
-
0034020186
-
Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging
-
Lo YMD, Leung SF, Chan LYS, et al. Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. Ann NY Acad Sci. 2000; 906: 99-101.
-
(2000)
Ann NY Acad Sci.
, vol.906
, pp. 99-101
-
-
Lo, Y.M.D.1
Leung, S.F.2
Chan, L.Y.S.3
-
29
-
-
29844443251
-
Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays
-
Sozzi G, Roz L, Conte D, et al. Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst. 2005; 97: 1848-1850.
-
(2005)
J Natl Cancer Inst.
, vol.97
, pp. 1848-1850
-
-
Sozzi, G.1
Roz, L.2
Conte, D.3
-
30
-
-
85000855990
-
A multicenter randomized controlled trial of adjuvant chemotherapy in nasopharyngeal carcinoma with residual plasma EBV DNA following primary radiotherapy or chemoradiotherapy [abstract]
-
(suppl). Abstract 5511
-
Chan ATC, Ngan RKC, Hui EP, et al. A multicenter randomized controlled trial of adjuvant chemotherapy in nasopharyngeal carcinoma with residual plasma EBV DNA following primary radiotherapy or chemoradiotherapy [abstract]. J Clin Oncol. 2012; 30 (suppl). Abstract 5511.
-
(2012)
J Clin Oncol.
, vol.30
-
-
Chan, A.T.C.1
Ngan, R.K.C.2
Hui, E.P.3
|